CVE-2015-3965
UnknownEPSS 2.94%
Last modified
CVE-2015-3965 is a vulnerability of currently unknown severity. Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.. EPSS estimates a 2.94% chance of exploitation in the next 30 days.
Description
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Metrics
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Pfizer | Symbiq Infusion System Firmware | <= 3.13 |
References
- https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01Third Party Advisory, US Government Resource
- https://ics-cert.us-cert.gov/advisories/ICSA-15-174-01Third Party Advisory, US Government Resource
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2015-3965?
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
How severe is CVE-2015-3965?
Severity scoring for CVE-2015-3965 is pending analysis. The EPSS model estimates a 2.94% probability of exploitation in the next 30 days.
How do I fix CVE-2015-3965?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
How Strix Helps
- How Strix found a critical auth bypass in etcdStrix autonomously discovered a critical authentication bypass in etcd, later designated CVE-2026-33413.
- Autonomous PentestingAI agents that find and validate exploitable vulnerabilities like this one across your applications.
- PR ReviewsPentest every pull request so vulnerable code is caught before it ships to production.
- AI Penetration TestingHow AI-driven penetration testing continuously covers your attack surface.
Related CVEs from 2015
- CVE-2015-3959The firmware in MNS before 4.5.6 on Belden GarrettCom Magnum…
- CVE-2015-3960The firmware in MNS before 4.5.6 on Belden GarrettCom Magnum…
- CVE-2015-3961The web-server component in MNS before 4.5.6 on Belden Garre…
- CVE-2015-3962Schneider Electric StruxureWare Building Expert MPM before 2…
- CVE-2015-3963Wind River VxWorks before 5.5.1, 6.5.x through 6.7.x before …
- CVE-2015-3964SMA Solar Sunny WebBox has hardcoded passwords, which makes …
- CVE-2015-3966The IPsec SA establishment process on Innominate mGuard devi…
- CVE-2015-3967Cross-site request forgery (CSRF) vulnerability on Janitza U…
- CVE-2015-3968The FTP service on Janitza UMG 508, 509, 511, 604, and 605 d…
- CVE-2015-3969Janitza UMG 508, 509, 511, 604, and 605 devices allow remote…
- CVE-2015-3970Multiple cross-site scripting (XSS) vulnerabilities in the w…
- CVE-2015-3971The debug interface on Janitza UMG 508, 509, 511, 604, and 6…
Are you affected by CVE-2015-3965?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST
